For instance, poly (adenosine diphosphate-ribose) polymerase 1 (PARP1) and breast cancer 1 (BRCA1) are a famous SL gene pair, leading to the first clinically approved SL-based cancer drug, PARP inhibitor (Lord and Ashworth, 2017). Here, PARP1 is linked to cancer.